AnalysisNews

VCEL today

$59.45+$0.42 (+0.71%)close Nov 11, 2026

Trend

DailyDowntrend (confirmed)

4 hourBullish

1 hourStrong Bullish

15 minSymmetric Triangle

5 minAscending Triangle

Daily trend turns up above $49.32

Key levels

Resistance$68.94

Resistance$63.00

Support$58.77

Support$55.41

Latest news & SEC filings

AnalystStephens & Co. keeps Overweight rating on Vericel, lifts price target to $68

SEC FilingVericel Corp filed an insider trading report (Form 4)

AnalystTruist Securities kept its Buy rating on Vericel (VCEL) and raised its price target to $65 from $52.

All VCEL news →

About Vericel

Vericel develops and sells cell-based treatments and biologic products for orthopedic repair and burn treatment. Its main offerings are MACI, a cartilage repair therapy for knee defects in adults, and Epicel, a cultured skin substitute for patients with extensive deep burns. The company also markets NexoBrid, a topical biologic for removing burn eschar, under a North American license. Vericel sells mainly to orthopedic surgeons, hospitals, and specialized burn centers in the United States.

Based on the company's 10-K filed Feb 26, 2026.

Nasdaq · Healthcare

Vericel Corp (VCEL)

$59.45+0.42 (+0.71%)
WATCHLISTGrade: B+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
43.4447.4451.4555.4559.45Oct 9Oct 19Oct 27Nov 4
High59.75
Low57.76
Open58.42
Volume781K
Avg Vol745K
VWAP58.90
30d High59.45
30d Low39.44
30d Chg+50.74%

What Is the Price Target for VCEL?

SEPT Low Target

$52.00

SEPT Mid Target

$58.00

SEPT High Target

$72.00

Analyst Consensus

$58.00

Current: $59.45Upside: -2.4%Confidence: 65%Method: Analyst Consensus

Is VCEL a Buy or Sell Right Now?

71
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Nov 5▲ UpEarnings5 articles
Vericel reported third-quarter 2026 earnings that beat expectations, with profit of $0.27 per share topping the $0.06 consensus and revenue of $85.371 million exceeding the $77.948 million forecast. The company also raised its full-year 2026 sales outlook to $344M-$346M from $330M-$340M, with the new midpoint above the $336.224 million analyst estimate. Shares closed at $51.78, up 2.45% on the day, though the stock traded in a wide range between $49.00 and $55.60 on volume of 2,638,948. The strong results and raised guidance signal positive momentum for the stock.
Critical news
Nov 5HIGHEarnings: growth/beat

Thesis

  • •Revenue growing 16.4% YoY with STRONG trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for VCEL.

Start Free Trial →

Is VCEL Overvalued or Undervalued?

Valuation Verdict

OVERVALUED

Methods Used

P/E Forward, P/B, PEG, Analyst Consensus

Fair Value

$43.16

58

Moat Score

NARROW

8/9

Piotroski Score

9.7

Altman Z-Score

What Is Smart Money Doing with VCEL?

Insider Signal

SELLING

0 buys / 12 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Recent Insider Activity

NameTitleTypeSharesValueDate
Flynn Sean C.officerBuy15,000$244KNov 5, 2026
Flynn Sean C.officerSale15,000$779KNov 5, 2026
SIEGAL JONATHANofficerBuy1,500$52KNov 5, 2026
SIEGAL JONATHANofficerSale1,500$79KNov 5, 2026
ZERBE ROBERT L MDdirectorBuy500$7KNov 5, 2026
ZERBE ROBERT L MDdirectorSale500$28KNov 5, 2026
ZERBE ROBERT L MDdirectorBuy2,500$33KNov 5, 2026
ZERBE ROBERT L MDdirectorSale2,500$129KNov 5, 2026
ZERBE ROBERT L MDdirectorBuy2,500$33KNov 4, 2026
ZERBE ROBERT L MDdirectorSale2,500$114KNov 4, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

VCEL Growth Story

Revenue YoY

16.4%

3yr Revenue CAGR

18.9%

EPS Growth YoY

60%

FCF Growth YoY

525.9%

Revenue Trend

STRONG

Dark Pool Trades for VCEL

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for VCEL, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:00:38$59.455,413$$322KBUY
21:00:16$59.453,954$$235KBUY
21:00:01$59.451,002$$60KBUY
21:00:00$59.451,661$$99KBUY
20:59:19$59.481,835$$109KBUY

5 dark pool trades shown · $$824K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Options Flow for VCEL

PREVIEW

SEPT Investing provides real-time options flow tracking for VCEL, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.

TypeStrikeExpiryDTEPremiumSizeTrade
CALL$75Apr 16156$$7203SWEEP

1 options trades shown · 100% calls

Unusual activity, GEX levels, max pain, and dealer positioning

See full options flow

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Vericel Corp (VCEL) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

VCEL — frequently asked questions

What is VCEL stock price today?

Vericel Corp (VCEL) is at $59.45, up 0.71% (+$0.42) at the Nov 11, 2026 close.

Why is VCEL stock moving today?

Latest VCEL news — Nov 10, 2026: Stephens & Co. keeps Overweight rating on Vericel, lifts price target to $68 · Nov 9, 2026: Vericel Corp filed an insider trading report (Form 4)

Why did VCEL stock move on Nov 5, 2026?

Vericel reported third-quarter 2026 earnings that beat expectations, with profit of $0.27 per share topping the $0.06 consensus and revenue of $85.371 million exceeding the $77.948 million forecast. The company also raised its full-year 2026 sales outlook to $344M-$346M from $330M-$340M, with the new midpoint above the $336.224 million analyst estimate.

What is the VCEL price target?

The average analyst price target for VCEL is $58.00, ranging from $52 to $72, based on 4 analysts. Latest: Truist Securities maintains on Oct 14, 2026.

What do analysts rate VCEL?

Analyst ratings for VCEL: 0 Buy, 8 Hold, 0 Sell — consensus Hold.

Did VCEL beat earnings?

VCEL last reported on Jul 30, 2026: EPS $0.04 vs -$0.03 expected — a beat of 238.4%.

What is VCEL's P/E ratio?

VCEL trades at a P/E of 94.7 vs a Healthcare average of 18.5.

Does VCEL pay a dividend?

VCEL does not currently pay a dividend.

What are VCEL support and resistance levels?

Support: $58.77, $55.41, $51.96. Resistance: $63.00, $68.94.

What are insiders doing with VCEL?

Insider activity: SELLING, 0 buys and 12 sells in the last 90 days.

What is the latest news on VCEL?

Nov 10, 2026: Stephens & Co. keeps Overweight rating on Vericel, lifts price target to $68 · Nov 9, 2026: Vericel Corp filed an insider trading report (Form 4) · Nov 9, 2026: Truist Securities kept its Buy rating on Vericel (VCEL) and raised its price target to $65 from $52.